Industry Told How To Categorize And Group Brexit-Related Manufacturing Changes
Executive Summary
The EU group for coordinating drug approvals through the mutual recognition and decentralized procedures has developed a non-exhaustive list of scenarios that companies with manufacturing processes in the UK may face following Brexit, and explains how to address these through appropriate variation applications.